Ampio Pharmaceuticals Inc.  – NYSE MKT: AMPE

The reason I have AMPE on my list is that there is a positive momentum in the news. More importantly, they have just put out the latest release on this in the past 15 days or so. Look at the last two press releases from AMPE.

Ampio Pharmaceuticals, Inc. Announces Positive Results for Ampion in Osteoarthritis of the Knee Clinical Trial –  (Wed, Aug 14)
Luoxis Diagnostics, Inc. announces positive results from first clinical study conducted with company’s proprietary diagnostic platform – (Thu, Jun 20)

I say the news is “positive” because even AMPE uses the word positive in its headlines. Also the product Ampion is achieving the results.  A 40% reduction in pain with improvement in overall quality of life with few, if any, adverse reactions. What more could they ask for out of this trial?

SEE AMPE IN STOCKGURU’S 12 BIOTECH BREAKOUT STOCKS

SEE THE ENTIRE LIST OF STOCKGURU’S 12 BIOTECH BREAKOUT STOCKS 

 

12-BIOTECH